Engimmune Therapeutics, a Swiss biotech company based in Basel developing novel T-cell receptor (TCR)-based therapeutics, has closed a CHF 15.5m seed financing round. The round was led by the investors Pureos Bio-ventures and Novo
Tags :Slider
Zuger Kantonalbank is acquiring Immofonds Asset Management, which acts, among other things, as the fund management for IMMOFONDS. Zuger Kantonalbank wants to increase its share in the real estate sector. Earlier in the year, the
GHR Rechtsanwälte advised Koa Switzerland & Ghana on the establishment of Senior Loan Facilities. In February 2022, Koa Switzerland as well as KOA Impact Ghana entered into senior loan facilities with IDH Farmfit Fund B.
SIG Group successfully placed newly issued shares raising gross proceeds of approximately CHF 213 million by way of an accelerated bookbuilding
Guess has entered into the revolving credit facility through its wholly-owned Swiss subsidiary, Guess Europe. The EUR 250 million sustainability-linked revolving credit facility has been signed with UBS Switzerland as Mandated Lead Arranger, Joint Bookrunner, Sustainability
Viseca has sold Contovista, a Swiss fintech company focus in data-based banking, to Finnova. Finnova, a Lenzburg-based banking software manufacturer, is taking over Contovista, based in Schlieren (Zurich), with retroactive effect
Bratschi’s Co-Head of Construction, Real Estate and Hotels, Ion Eglin (pictured) has been elected as Chairman of the Board of Directors of Bratschi. The new appointment came during the Annual General Meeting held on
Bruker Corporation, a NASDAQ-listed US tech company in the analytical instrumentation sector, has acquired a stake in Swiss firm Tofwerk. Details of the transaction have not been disclosed. Tofwerk develops time-of-flight mass spectrometers and
Baker McKenzie Switzerland, along with other Baker McKenzie offices, advised Feintool International Holding (“Feintool”) on its capital increase by approximately CHF 202 million via a rights offering. UBS acted as sole global coordinator and bookrunner while
Demant has negotiated an agreement with the intention to divest its Hearing Implants business, Oticon Medical, to Cochlear Limited for a total consideration of DKK 850 million. The transaction follows a review of strategic options for
